Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, today provided an update on the development of its telehealth platform infrastructure as part of its broader digital health strategy. The platform is designed to support remote patient engagement, care coordination, and the integration of AI-driven healthcare analytics tools within a technology-enabled healthcare environment.
The company’s telehealth platform aims to facilitate communication between patients, healthcare providers, and related service participants while enabling structured data collection and workflow coordination across multiple points of care. The platform is intended to integrate with Catalyst Crew’s broader AI healthcare platform, including its CardioAI, PulmoAI, and NeuroAI modules, which are being developed to support data-driven analytics and clinical decision-support capabilities. Through this integration, the company seeks to establish a unified digital infrastructure capable of supporting both healthcare services coordination and analytics-driven insights.
Development efforts are currently focused on core platform functionality, including system architecture, data integration, user workflows, and operational processes. The company is also evaluating approaches to ensure scalability, interoperability, and integration with existing healthcare systems and technologies.
Catalyst Crew is leveraging its wholly-owned subsidiary in Venezuela to support local platform development, operational coordination, and infrastructure planning. Initial efforts are concentrated on Venezuela, with potential expansion into other Latin American markets as development progresses. The company’s platform is intended to support healthcare providers and related service participants and does not replace licensed medical professionals or clinical decision-making.
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated: “We are focused on building a scalable and integrated telehealth platform that can support healthcare coordination and data-driven insights. Our approach is centered on developing infrastructure that can operate within real-world healthcare environments and support future expansion across Latin America.”
The company continues to advance its digital health and AI platform and evaluate opportunities for expansion across emerging markets. For more information, visit https://catalystcrewai.com or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
